Showing results (211-220 of 404) with videos related to

Sort By:
Pageof 41
Revue Des Maladies Respiratoires|October 7, 2003
[Costo-vertebral hydatid disease: the role of MRI]S Maalej, D Belhabib, S Hantous, et al.
Anesthesiology|November 20, 1998
Comparative clinical pharmacology of rocuronium, cisatracurium, and their combinationM Naguib, A H Samarkandi, A Ammar, et al.
La Tunisie Medicale|March 26, 2002
[Muscle metastasis of a primary bronchial carcinoma]D Belhabib, S Maalej, S Fenniche, et al.
Antibiotics (Basel, Switzerland)|January 21, 2023
Antibiofilm and Anti-Quorum-Sensing Activities of Novel Pyrazole and Pyrazolo[1,5-a]pyrimidine Derivatives as Carbonic Anhydrase I and II Inhibitors: Design, Synthesis, Radiosterilization, and Molecular Docking StudiesAhmed Ragab, Sawsan A Fouad, Yousry A Ammar, et al.
Current Eye Research|November 2, 2011
A comparison of active ingredients and preservatives between brand name and generic topical glaucoma medications using liquid chromatography-tandem mass spectrometryMalik Y Kahook, Robert D Fechtner, L Jay Katz, et al.
Carbohydrate Polymers|September 5, 2025
Novel antibacterial, antioxidant, and anti-inflammatory aminated chitosan hybrid quinoline Schiff base as multi-target agent: Design, molecular docking, and toxicity assessmentYasser M Abdel-Baky, Ahmed Ragab, Moustafa S Abusaif, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1988
Prognostic value of blood and bone marrow T-colony-forming cells (T-CFC) in patients with lymphadenopathy syndrome (LAS)Y Lunardi-Iskandar, V Georgoulias, D Vittecoq, et al.
Bioorganic & Medicinal Chemistry|July 18, 2006
New quinoxaline 1,4-di-N-oxides. Part 1: Hypoxia-selective cytotoxins and anticancer agents derived from quinoxaline 1,4-di-N-oxidesKamelia M Amin, Magda M F Ismail, Eman Noaman, et al.
European Journal of Medicinal Chemistry|March 19, 2010
New quinoxaline 1, 4-di-N-oxides: anticancer and hypoxia-selective therapeutic agentsMagda M F Ismail, Kamelia M Amin, Eman Noaman, et al.
Tissue & Cell|March 15, 2024
Effect of intermittent fasting on adriamycin-induced nephropathy: Possible underlying mechanismsFathy H Elsaid, Abdelaziz M Hussein, Elsayed A Eid, et al.
Pageof 41